Limiting AAA With Metformin (LIMIT) Trial (NCT04500756)
LIMItIng AAA With meTformin (LIMIT) Trial
🩺 Plain-English Summary (8th-Grade Level)
In this research, the investigators are looking at the effects of a drug called metformin may have on the growth of abdominal aortic aneurysm (AAA)s. AAA is an abnormal enlargement of the aorta, which is the large artery in the abdomen (stomach area). The enlargement of the aorta carries a risk that it will rupture and cause life-threatening bleeding in the abdomen (belly). In this study the investigators hope to learn how metformin is associated with the enlargement or change in size of the AAA in study participants. Smaller studies have suggested that metformin may reduce the rate at which aortic aneurysms enlarge. This study will test this question: does metformin prevent AAAs from growing larger?
Who can join: Review the eligibility criteria below.
Location: Stanford Hospital and Clinics — Stanford, California
Age range: 50 Years to 95 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Stanford Hospital and Clinics — Stanford, California
📞 Contact the Study Coordinator
Phone: (412) 452-7137
Email: ssami@stanford.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Abdominal Aortic Aneurysm
- The Long-Term EVAR Assessment and Follow-Up (LEAF) Study for the AFX2 System — Lebanon, New Hampshire
- Post-Approval Study of the TREO Abdominal Stent-Graft System — Phoenix, Arizona
- GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study — Stanford, California
- First In Human Study for Small to Medium-sized Abdominal Aortic Aneurysm (AAA) — Randwick, New South Wales
- Global Fenestrated Anaconda Clinical STudy — Melbourne, Victoria
- The PREHAAAB Trial: Multimodal Prehabilitation for Patients Awaiting Open Abdominal Aortic Aneurysm Repair — Montreal, Quebec
Explore by condition: All Abdominal Aortic Aneurysm clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.